Florida AG Sues Pfizer and CEO Bourla Over COVID Vaccine Marketing
PFE sits 20% above its 52-week low of $23.62 on light trading volume (0.2× avg).
Summary
Florida's Attorney General has filed a lawsuit against Pfizer and CEO Albert Bourla, alleging deceptive marketing of the company's COVID-19 vaccine. This is a new legal risk for Pfizer, which has faced prior litigation and regulatory scrutiny related to its COVID products. The lawsuit names the CEO personally, adding reputational and potential financial exposure. Pfizer's stock is trading near its 52-week high, so this news could trigger profit-taking. The company has not yet commented on the lawsuit.
At the time of this announcement, PFE was trading at $28.32 on NYSE in the Life Sciences sector, with a market capitalization of approximately $161.4B. The 52-week trading range was $23.62 to $29.21. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.